• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison — Texas, July–August 2021

Mary Wilson

Well-known member
Early Release / September 21, 2021 / 70

Liesl M. Hagan, MPH[SUP]1,[/SUP]*; David W. McCormick, MD[SUP]1[/SUP][SUP],2,[/SUP]*; Christine Lee, PhD[SUP]1[/SUP]; Sadia Sleweon, MPH[SUP]1[/SUP]; Lavinia Nicolae, PhD[SUP]1[/SUP]; Thomas Dixon[SUP]3[/SUP]; Robert Banta, MSN[SUP]3[/SUP]; Isaac Ogle, MSN[SUP]3[/SUP]; Cristen Young[SUP]3[/SUP]; Charles Dusseau[SUP]3[/SUP]; Shawn Salmonson[SUP]3[/SUP]; Charles Ogden, MPH[SUP]3[/SUP]; Eric Godwin[SUP]3[/SUP]; TeCora Ballom, DO[SUP]3[/SUP]; Tara Ross[SUP]3[/SUP]; Hannah Browne[SUP]1[/SUP]; Jennifer L. Harcourt, PhD[SUP]1[/SUP]; Azaibi Tamin, PhD[SUP]1[/SUP]; Natalie J. Thornburg, PhD[SUP]1[/SUP]; Hannah L. Kirking, MD[SUP]1[/SUP]; Phillip P. Salvatore, PhD[SUP]1[/SUP]; Jacqueline E. Tate, PhD[SUP]1[/SUP]

Incarcerated populations have experienced disproportionately higher rates of COVID-19–related illness and death compared with the general U.S. population, due in part to congregate living environments that can facilitate rapid transmission of SARS-CoV-2, the virus that causes COVID-19, and the high prevalence of underlying medical conditions associated with severe COVID-19 (1,2). The SARS-CoV-2 B.1.617.2 (Delta) variant has caused outbreaks among vaccinated and unvaccinated persons in congregate settings and large public gatherings (3,4). During July 2021, a COVID-19 outbreak involving the Delta variant was identified in a federal prison in Texas, infecting 172 of 233 (74%) incarcerated persons in two housing units. The Federal Bureau of Prisons (BOP) partnered with CDC to investigate. CDC analyzed data on infection status, symptom onset date, hospitalizations, and deaths among incarcerated persons. The attack rate was higher among unvaccinated versus fully vaccinated persons (39 of 42, 93% versus 129 of 185, 70%; p = 0.002).[SUP]†[/SUP] Four persons were hospitalized, three of whom were unvaccinated, and one person died, who was unvaccinated. Among a subset of 70 persons consenting to an embedded serial swabbing protocol, the median interval between symptom onset and last positive reverse transcription–polymerase chain reaction (RT-PCR) test result in fully vaccinated versus unvaccinated persons was similar (9 versus 11 days, p = 0.37). One or more specimens were culture-positive from five of 12 (42%) unvaccinated and 14 of 37 (38%) fully vaccinated persons for whom viral culture was attempted. In settings where physical distancing is challenging, including correctional and detention facilities, vaccination and implementation of multicomponent prevention strategies (e.g., testing, medical isolation, quarantine, and masking) are critical to limiting SARS-CoV-2 transmission (5).
Investigation and Response
...

https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e3.htm?s_cid=mm7038e3_w#suggestedcitation
 
Back
Top